The home of whole-person & compassionate cancer care

Uterine Cancer Prognosis

Prognosis is a specialized medical opinion that refers to the likely outcome of a disease. Uterine cancer prognosis depends on various factors, including the stage and grade of the disease, the appearance of cancerous cells and the affect of progesterone on the cancer. Prognosis is “favorable” if the cancer responds well to treatment and “unfavorable” if the cancer responds poorly or not at all. It is imperative to know that the prognosis of uterine cancer is only a prediction, and its accuracy still does not present a 100 percent guarantee of the outcome for a patient. Uterine cancer prognosis is important as it helps women and their loved ones plan treatment options, consider certain lifestyle changes and make decisions regarding their finances and quality of life.

Prognosis also helps doctors determine uterine cancer survival rates. 92 percent of women diagnosed with the cancer survive for 1-year. 5 year survival rate for localized cancer (cancer that has not spread to other organs) is 95 percent. 5 year survival rate drops to 23 percent for uterine cancer that spreads beyond the uterus, affecting distant organs.

The prognosis of the condition also depends on the health of the patient. Generally, patients in good physical and mental health are likely to have favorable prognosis than those who smoke, drink or are not physically active. Individuals with diabetes mellitus, hypertension, obesity, abnormal menstrual cycles, breast cancer, nonpolyposis colorectal cancer or those who have had radiation therapy are at increased risk of the cancer and report poor chances of survival.

At Cancer Treatment Centers of America, they offer integrative, whole person care. Contact one of their representatives all day, every day by phone or online chat. Cancer Treatment Centers of America has Hospitals in Philadelphia Pennsylvania, Zion Illinois, Tulsa Oklahoma, and Goodyear Arizona. For more information on their integrative treatment options for Uterine Cancer call today.